NECLIFE: Nectar Lifesciences Limited has informed the Exchange about Copy of Newspaper Publication of Corrigendum to the Notice of 2025-26/01st Extraordinary General Meeting ( EGM ).
NECLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nectar Lifesciences has published a corrigendum to the notice of its 1st EGM of FY2025-26, scheduled for Monday, August 4, 2025 at 10:00 AM at its registered office in Punjab. The Board, at its meeting on July 23, 2025, approved a mode of rewarding shareholders through special dividends and/or a Buyback of Equity Shares, or a mix of both. The corrigendum updates Item No. 3 of the Explanatory Statement to explicitly include this shareholder reward mechanism alongside the existing plans for debt repayment, new project investment, and general corporate purposes. The corrigendum was published in Business Standard (English, all editions) and Desh Sewak (Punjabi) on July 24, 2025, and will be read as part of the original EGM notice.
Positive signal for shareholders — the Board has formally approved considering a special dividend and/or share buyback, indicating potential capital return. The actual quantum and form will depend on the outcome of the EGM on August 4, 2025 and the proceeds from the proposed transaction referenced in the EGM agenda.